ANALYSIS OF TUBERCULOSIS PATIENT CHARACTERISTICS OF GORONTALO CITY HOSPITAL USING K-MEANS CLUSTERING METHOD
Analisis Karakteristik Pasien Tuberkulosis Rumah Sakit Kota Gorontalo Menggunakan Metode K-Means Clustering
Downloads
Latar Belakang Tuberkulosis (TB) merupakan masalah kesehatan utama di Indonesia, khususnya di Gorontalo, dengan penyebaran yang tinggi akibat ventilasi yang buruk, kepadatan penduduk, dan pola hidup yang tidak sehat. Tujuan Menganalisis karakteristik pasien TB di salah satu rumah sakit kota Gorontalo menggunakan K-Means Clustering. Metode Data meliputi usia, jenis kelamin, riwayat TB, status HIV, riwayat diabetes, hipertensi, resistensi obat, efek samping obat, dan hasil pengobatan dianalisis jumlah clusternya menggunakan metode k-means. Hasil Analisis menghasilkan tiga cluster. Cluster 0 (219 individu): mayoritas perempuan (63,5%), usia rata-rata 45,37 tahun, skor alamat rendah (0,493), resistensi dan terapi rendah (6,4%), tidak ada penyakit penyerta, semua mengalami efek samping (100%), dan survival rate 4,1%. Klaster 1 (150 individu): usia rata-rata 52,21 tahun, skor alamat lebih tinggi (0,773), resistensi 7,3%, terapi 5,3%, komorbiditas 100%, semua mengalami kejadian buruk, dan tingkat kelangsungan hidup 4,7%. Klaster 2 (98 individu): usia rata-rata 48,58 tahun, skor alamat 0,653, resistensi dan terapi sangat rendah (2%), tidak ada efek samping, 42,9% memiliki komorbiditas, dan tingkat kelangsungan hidup tertinggi (12,2%). Kesimpulan Ada tiga klaster yang diperoleh dari analisis menggunakan K-Means. Pengelompokan mendukung intervensi spesifik seperti manajemen komorbiditas atau pengawasan intensif, meningkatkan program pengendalian TB di Gorontalo.
Furin J, Cox H, Pai M. Tuberculosis. Vol. 393, The Lancet. Lancet Publishing Group; 2019. p. 1642–56 https://doi.org/10.1016/S0140-6736(19)30308-3
Falzon D, Zignol M, Bastard M, Floyd K, Kasaeva T. The impact of the COVID-19 pandemic on the global tuberculosis epidemic. Vol. 14, Frontiers in Immunology. Frontiers Media SA; 2023 https://doi.org/10.1097/01.nme.0000613628.36961.64
Perkins, A. (2020). Tuberculosis facts. Nursing Made Incredibly Easy!. https://doi.org/10.1097/01.nme.0000613628.36961.64.
Nadjamuddin, M., & Junita, N. (2023). Find Tuberculosis Treat It Until It Is Healed. Ejoin : Jurnal Pengabdian Masyarakat. https://doi.org/10.55681/ejoin.v2i10.1627.
Nurany H, Raharjo M, Sakundarno Adi M. Environmental Quality Factors with The Incidence of Pulmonary Tuberculosis: A Literature Review. Serambi Engineering. 2022;VII(3).
H, Tosepu R, Savitri Effendy D. Tuberculosis Epidemiology and Medical Treatment Efforts in Indonesia in the Year 2020. KnE Life Sciences. 2022 Sep 13;
Indri Yosua M, Ningsih F, Ovany R, Eka Harap Palangka Raya Stik, Raya P, Tengah K. Relationship With House Environmental Conditions Event Of Tuberculosis (TB) Lungs. 2022 [Internet]. Available from: http://journal.umpalangkaraya.ac.id/index.php/jsm
Dinkes Provinsi Gorontalo. Profil Kesehatan Provinsi Gorontalo 2022. 2023.
Pakaya R. Factors related to Pulmonary Tuberculosis Incident in Public Health Center of Limboto Year 2018. KESMAS UWIGAMA: Jurnal Kesehatan Masyarakat. 2020 Jul 9;6(1):1–13.
Kosorok MR, Laber EB. Annual Review of Statistics and Its Application Precision Medicine. 2019; Available from: https://doi.org/10.1146/annurev-statistics-
Wang Y, Zheng D. The importance of precision medicine in modern molecular oncology. Vol. 100, Clinical Genetics. John Wiley and Sons Inc; 2021. p. 248–57.
Denny JC, Collins FS. Precision medicine in 2030—seven ways to transform healthcare. Cell. 2021 Mar 18;184(6):1415–9.
Choi D, Shrestha D, Xiang A, Drake B, Ozturk O, Haidarian H, et al. Patient Clustering via Integrated Profiling of Clinical and Digital Data. In: International Conference on Information and Knowledge Management, Proceedings. Association for Computing Machinery; 2023. p. 3818–22.
Wang T, Chen R, Liu W, Yu M. Structure-preserving integrated analysis for risk stratification with application to cancer staging. Biostatistics. 2022 Jul 1;23(3):990–1006.
Dong B, He Z, Li Y, Xu X, Wang C, Zeng J. Improved Conventional and New Approaches in the Diagnosis of Tuberculosis. Vol. 13, Frontiers in Microbiology. Frontiers Media S.A.; 2022.
Kafle MP. Treating tuberculosis in special situations. Bangladesh Journal of Medicine. 2024 Jun 6;141–2.
Li X, van Giessen A, Altunkaya J, Slieker RC, Beulens JWJ, ‘T Hart LM, et al. Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups. Diabetes Care. 2023 Jul 1;46(7):1395–403.
Tchakounte Youngui B, Tchounga BK, Graham SM, Bonnet M. Tuberculosis Infection in Children and Adolescents. Vol. 11, Pathogens. MDPI; 2022.
Marlina L, Darmansyah D. Descriptive Study of Certainty Level Towards Risk of Tuberculosis Disease in Productive Ages. KnE Life Sciences. 2021 Mar 15;1063–8.
Togun T. Childhood tuberculosis in high burden settings. Vol. 63, EBioMedicine. Elsevier B.V.; 2021.
Mustapha MG, Ashir GM, Rabasa AI, Farouk AG, Elechi HA, Alhaji MA. Childhood tuberculosis: Characteristics and peculiarities. Niger J Paediatr. 2020 Aug 6;47(3):190–200.
Whittaker E, Lopez-Varela E, Broderick C, Seddon JA. Examining the complex relationship between tuberculosis and other infectious diseases in children: A review. Vol. 7, Frontiers in Pediatrics. Frontiers Media S.A.; 2019.
Robsky KO, Chaisson LH, Naufal F, Delgado-Barroso P, Alvarez-Manzo HS, Golub JE, et al. Number Needed to Screen for Tuberculosis Disease Among Children: A Systematic Review. Vol. 151, Pediatrics. 2023.
Di Gennaro F, Vittozzi P, Gualano G, Musso M, Mosti S, Mencarini P, et al. Active pulmonary tuberculosis in elderly patients: A 2016–2019 retrospective analysis from an Italian referral hospital. Antibiotics. 2020 Aug 1;9(8):1–10.
Olmo-Fontánez AM, Turner J. Tuberculosis in an Aging World. Vol. 11, Pathogens. MDPI; 2022.
Hase I, Toren KG, Hirano H, Sakurai K, Horne DJ, Saito T, et al. Pulmonary Tuberculosis in Older Adults: Increased Mortality Related to Tuberculosis Within Two Months of Treatment Initiation. Drugs Aging. 2021 Sep 1;38(9):807–15.
Kunoor A, Reddy S, Gopalakrishnan V, Rakesh P, Kadayara A, Haridas N, et al. Burden of comorbidity and treatment outcome in tuberculosis – A descriptive study from a tertiary care center, Kerala, India. PULMON. 2023;25(2):44.
Chen Q, Che Y, Xiao Y, Jiang F, Chen Y, Zhou J, et al. Impact of Multimorbidity Subgroups on the Health Care Use and Clinical Outcomes of Patients With Tuberculosis: A Population-Based Cohort Analysis. Front Public Health. 2021 Oct 8;9.
Cáceres G, Calderon R, Ugarte-Gil C. Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression. Vol. 9, Therapeutic Advances in Infectious Disease. SAGE Publications Ltd; 2022.
Vázquez García JC, Sada Díaz E, Rivera Martínez E, Narváez Porras O, Salazar Lezama MA. Tuberculosis associated with HIV infection. Rev Invest Clin. 1994;46(6):473–7.
Telisinghe L, Ruperez M, Amofa-Sekyi M, Mwenge L, Mainga T, Kumar R, et al. Does tuberculosis screening improve individual outcomes? A systematic review. EClinicalMedicine. 2021 Oct 1;40.
Lewicki J, Religioni U, Merks P. Evaluation of the community pharmacy comorbidities screening service on patients with chronic diseases. Patient Prefer Adherence. 2021;15:1611–9.
Leddy AM, Jaganath D, Triasih R, Wobudeya E, Bellotti De Oliveira MC, Sheremeta Y, et al. Social Determinants of Adherence to Treatment for Tuberculosis Infection and Disease Among Children, Adolescents, and Young Adults: A Narrative Review. J Pediatric Infect Dis Soc. 2022 Oct 1;11:S79–84.
- Every manuscript submitted to must observe the policy and terms set by the Jurnal Berkala Epidemiologi
- Publication rights to manuscript content published by the Jurnal Berkala Epidemiologi is owned by the journal with the consent and approval of the author(s) concerned. (download copyright agreement)
- Complete texts of electronically published manuscripts can be accessed free of charge if used for educational and research purposes according to copyright regulations.
JBE by Universitas Airlangga is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.